APOA1 and coronary artery disorder: The levels of IgM against ApoA-I and HNE-ApoA-I peptides in CAD patients with 30%~70% and >70% stenosis were statistically significantly lower than HCs and CAD patients with <30% stenosis (Figure 3C,D).